Douglas A. Roeder, Director at TANDEM DIABETES CARE INC (TNDM), sold 599,838 shares at $70.42 ($42.2M) on 2019-08-28, disclosed to the SEC on 2019-08-29.
Open-market sale of $42.2M TNDM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.10 | 1,191 | $83K | 0.2% |
| 2 | $70.10 | 1,191 | $83K | 0.2% |
| 3 | $70.10 | 122,018 | $8.6M | 20.3% |
| 4 | $70.10 | 122,018 | $8.6M | 20.3% |
| 5 | $70.42 | 166,704 | $11.7M | 27.8% |
| 6 | $70.42 | 1,628 |
| $115K |
| 0.3% |
| 7 | $70.42 | 1,628 | $115K | 0.3% |
| 8 | $70.42 | 166,704 | $11.7M | 27.8% |
| 9 | $71.00 | 162 | $12K | 0.0% |
| 10 | $71.00 | 16,594 | $1.2M | 2.8% |
| Total | $70.30 avg | 599,838 | $42.2M | 100% |
| Filing → |
| SENS | BUY | 2026-03-16 | $100K | — | Filing → |
| SENS | BUY | 2025-11-10 | $87K | — | Filing → |
| SENS | BUY | 2024-12-20 | $38K | — | Filing → |